Literature DB >> 31912206

Severe flu management: a point of view.

Antoni Torres1, Ignacio-Martin- Loeches2,3, Wendy Sligl4,5, Nelson Lee4.   

Abstract

Annual flu seasons are typically characterized by changes in types and subtypes of influenza, with variations in terms of severity. Despite remarkable improvements in the prevention and management of patients with suspected or laboratory-confirmed diagnosis of influenza, annual seasonal influenza continues to be associated with a high morbidity and mortality. Admission to the intensive care unit is required for patients with severe forms of seasonal influenza infection, with primary pneumonia being present in most of the cases. This review summarizes the most recent knowledge on the diagnosis and treatment strategies in critically ill patients with influenza, focused on diagnostic testing methods, antiviral therapy, use of corticosteroids, antibacterial and antifungal therapy, and supportive measures. The review focuses on diagnostic testing methods, antiviral therapy, use of corticosteroids, antibacterial and antifungal therapy, supportive measures and relevant existing evidence, in order to provide the non-expert clinician a useful overview. An enhanced understanding of current diagnostic and treatment aspects of influenza infection can contribute to improve outcomes and reduce mortality among ICU patients with influenza.

Entities:  

Keywords:  Antivirals; Corticosteroids; ICU; Influenza; Mortality; Pneumonia

Year:  2020        PMID: 31912206     DOI: 10.1007/s00134-019-05868-8

Source DB:  PubMed          Journal:  Intensive Care Med        ISSN: 0342-4642            Impact factor:   17.440


  70 in total

1.  Risk Factors for Noninvasive Ventilation Failure in Critically Ill Subjects With Confirmed Influenza Infection.

Authors:  Alejandro Rodríguez; Cristina Ferri; Ignacio Martin-Loeches; Emili Díaz; Joan R Masclans; Federico Gordo; Jordi Sole-Violán; María Bodí; Francesc X Avilés-Jurado; Sandra Trefler; Monica Magret; Gerard Moreno; Luis F Reyes; Judith Marin-Corral; Juan C Yebenes; Andres Esteban; Antonio Anzueto; Stefano Aliberti; Marcos I Restrepo
Journal:  Respir Care       Date:  2017-07-11       Impact factor: 2.258

2.  Early Neuromuscular Blockade in the Acute Respiratory Distress Syndrome.

Authors:  Marc Moss; David T Huang; Roy G Brower; Niall D Ferguson; Adit A Ginde; M N Gong; Colin K Grissom; Stephanie Gundel; Douglas Hayden; R Duncan Hite; Peter C Hou; Catherine L Hough; Theodore J Iwashyna; Akram Khan; Kathleen D Liu; Daniel Talmor; B Taylor Thompson; Christine A Ulysse; Donald M Yealy; Derek C Angus
Journal:  N Engl J Med       Date:  2019-05-19       Impact factor: 91.245

Review 3.  Noninvasive mechanical ventilation in high-risk pulmonary infections: a clinical review.

Authors:  Antonio M Esquinas; S Egbert Pravinkumar; Raffaele Scala; Peter Gay; Arie Soroksky; Christophe Girault; Fang Han; David S Hui; Peter J Papadakos; Nicolino Ambrosino
Journal:  Eur Respir Rev       Date:  2014-12

4.  Enteric absorption and pharmacokinetics of oseltamivir in critically ill patients with pandemic (H1N1) influenza.

Authors:  Robert E Ariano; Daniel S Sitar; Sheryl A Zelenitsky; Ryan Zarychanski; Amarnath Pisipati; Stéphane Ahern; Salmaan Kanji; Jordi Rello; Anand Kumar
Journal:  CMAJ       Date:  2010-02-16       Impact factor: 8.262

5.  Superiority of transcriptional profiling over procalcitonin for distinguishing bacterial from viral lower respiratory tract infections in hospitalized adults.

Authors:  Nicolas M Suarez; Eleonora Bunsow; Ann R Falsey; Edward E Walsh; Asuncion Mejias; Octavio Ramilo
Journal:  J Infect Dis       Date:  2015-01-29       Impact factor: 5.226

Review 6.  Comparison of Efficacy of Intravenous Peramivir and Oral Oseltamivir for the Treatment of Influenza: Systematic Review and Meta-Analysis.

Authors:  Jonghoo Lee; Ju Hee Park; Hyeyoung Jwa; Yee Hyung Kim
Journal:  Yonsei Med J       Date:  2017-07       Impact factor: 2.759

7.  Whole Genome Sequencing of A(H3N2) Influenza Viruses Reveals Variants Associated with Severity during the 2016⁻2017 Season.

Authors:  Bruno Simon; Maxime Pichon; Martine Valette; Gwendolyne Burfin; Mathilde Richard; Bruno Lina; Laurence Josset
Journal:  Viruses       Date:  2019-01-28       Impact factor: 5.048

8.  Routine molecular point-of-care testing for respiratory viruses in adults presenting to hospital with acute respiratory illness (ResPOC): a pragmatic, open-label, randomised controlled trial.

Authors:  Nathan J Brendish; Ahalya K Malachira; Lawrence Armstrong; Rebecca Houghton; Sandra Aitken; Esther Nyimbili; Sean Ewings; Patrick J Lillie; Tristan W Clark
Journal:  Lancet Respir Med       Date:  2017-04-06       Impact factor: 30.700

9.  The association between serum biomarkers and disease outcome in influenza A(H1N1)pdm09 virus infection: results of two international observational cohort studies.

Authors:  Richard T Davey; Ruth Lynfield; Dominic E Dwyer; Marcello H Losso; Alessandro Cozzi-Lepri; Deborah Wentworth; H Clifford Lane; Robin Dewar; Adam Rupert; Julia A Metcalf; Sarah L Pett; Timothy M Uyeki; Jose Maria Bruguera; Brian Angus; Nathan Cummins; Jens Lundgren; James D Neaton
Journal:  PLoS One       Date:  2013-02-27       Impact factor: 3.240

10.  Serum Procalcitonin Measurement and Viral Testing to Guide Antibiotic Use for Respiratory Infections in Hospitalized Adults: A Randomized Controlled Trial.

Authors:  Angela R Branche; Edward E Walsh; Roberto Vargas; Barbara Hulbert; Maria A Formica; Andrea Baran; Derick R Peterson; Ann R Falsey
Journal:  J Infect Dis       Date:  2015-04-24       Impact factor: 5.226

View more
  6 in total

1.  A Murine Model for Enhancement of Streptococcus pneumoniae Pathogenicity upon Viral Infection and Advanced Age.

Authors:  Basma H Joma; Nalat Siwapornchai; Vijay K Vanguri; Anishma Shrestha; Sara E Roggensack; Bruce A Davidson; Albert K Tai; Anders P Hakansson; Simin N Meydani; John M Leong; Elsa N Bou Ghanem
Journal:  Infect Immun       Date:  2021-07-15       Impact factor: 3.441

2.  Early oseltamivir treatment improves survival in critically ill patients with influenza pneumonia.

Authors:  Gerard Moreno; Alejandro Rodríguez; Jordi Sole-Violán; Ignacio Martín-Loeches; Emili Díaz; María Bodí; Luis F Reyes; Josep Gómez; Juan Guardiola; Sandra Trefler; Loreto Vidaur; Elisabet Papiol; Lorenzo Socias; Carolina García-Vidal; Eudald Correig; Judith Marín-Corral; Marcos I Restrepo; Jonathan S Nguyen-Van-Tam; Antoni Torres
Journal:  ERJ Open Res       Date:  2021-03-08

Review 3.  Update in Viral Infections in the Intensive Care Unit.

Authors:  Paraskevi C Fragkou; Charalampos D Moschopoulos; Emmanouil Karofylakis; Theodoros Kelesidis; Sotirios Tsiodras
Journal:  Front Med (Lausanne)       Date:  2021-02-23

4.  Clinical characteristics, risk factors and antiviral treatments of influenza in immunosuppressed inpatients in Beijing during the 2015-2020 influenza seasons.

Authors:  Yafen Liu; Yue Wang; Huan Mai; YuanYuan Chen; Baiyi Liu; YiSi Liu; Ying Ji; Xu Cong; Yan Gao
Journal:  Virol J       Date:  2022-01-15       Impact factor: 4.099

5.  Anti-high mobility group box 1 monoclonal antibody suppressed hyper-permeability and cytokine production in human pulmonary endothelial cells infected with influenza A virus.

Authors:  Takahiro Namba; Mitsuru Tsuge; Masato Yashiro; Yukie Saito; Keyue Liu; Masahiro Nishibori; Tsuneo Morishima; Hirokazu Tsukahara
Journal:  Inflamm Res       Date:  2021-08-29       Impact factor: 4.575

6.  [58/m-fever, cough and severe hypoxemia : Preparation for the medical specialist examination: part 65].

Authors:  M Seneghini; W Albrich
Journal:  Internist (Berl)       Date:  2021-07-15       Impact factor: 0.743

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.